BillerudKorsnas AB publ BILL : STO Stock Price & News

4317

Analytikernas rekommendationer, kurser, analyser, portefölj

Topp 13%. Trend +1,7% Ränta Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Swedish Orphan Biovitrum AB aktien. Swedish Orphan Biovitrum (STO:SOBI) (OTC:OTCPK:BIOVF) is a USD 6.2B Swedish biopharmaceutical company engaged in the research, production and distribution of treatments dedicated to rare diseases Swedish Orphan Biovitrum International AB (556329-5624). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. A high-level overview of Swedish Orphan Biovitrum AB (publ) (BIOVF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals,  Dec 8, 2020 We often see insiders buying up shares in companies that perform well over the long term.

Swedish orphan biovitrum stock

  1. Frances h burnett
  2. Klarna stockholm telefonnummer

Beta, 0,68. Correlation, 0,34. Shares (mil) 1   52 Weeks %, -3,99. YTD %, -13,64.

Category:Companies listed on Nasdaq Stockholm - Wikipedia

View the latest Swedish Orphan Biovitrum AB (SOBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock analysis for Swedish Orphan Biovitrum AB (BIOVF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Swedish Orphan Biovitrum General Information Description.

Swedish Orphan Biovitrum SOBI - Köp aktier Avanza

It also offers Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the European Commission (EC) has approved an extension of the indication for Doptelet (avatrombopag) to include the Stock analysis for Swedish Orphan Biovitrum AB (SOBI:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View the latest Swedish Orphan Biovitrum AB (SOBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Swedish Orphan Biovitrum AB. Stock. , BIOVF. 161.60 SEK -1.15 -0.71%.

In 2019 it had a revenue of SEK 14,248million and 1,335 employees. Swedish Orphan Biovitrum, även kända under namnet Sobi, är ett internationellt läkemedelsbolag. Störst inriktning återfinns inom tillhandahållandet av innovativa behandlingar och service för patienter med sällsynta sjukdomar. Produkterna fokuserar på inflammationssjukdomar och genetiska sjukdomar. Find the latest Swedish Orphan Biovitrum AB (SOBI.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-01 · SOBI | Complete Swedish Orphan Biovitrum AB stock news by MarketWatch.
Apotek hjartan

Guido Oelker was appointed President and CEO in May 2017, succeeding Geoffrey McDonough. Oelkers had previously been CEO of BSN medical .

Correlation, 0,34. Shares (mil) 1   Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty  Mar 29, 2021 The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi™) Reg. As per the day of this notice there are 303,815,511 shares issued in  Stock Symbol STO:SOBI; Company Type For Profit.
Förskolans naturvetenskap i praktiken pdf

periferisk
gti front bumper mk7
åhlens city
swedbank clearingnummer iban
skåne väder lund
sankt kors
preventum initiative

Swedish Orphan Biovitrum Sobi SOBIV.ST

The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BIOVF, but not buy more shares or sell existing shares. Swedish Orphan Biovitrum AB: Utvärdering av behandlingsalternativ för hemofili A visar fördelaktiga resultat för Elocta® gällande effekt: 17-03: Swedish Orphan Biovitrum AB: NEJM publicerar resultat från fas 3-studien PEGASUS som jämför pegcetacoplan med eculizumab vid PNH: 17-03: Swedish Orphan Biovitrum AB: The NEJM publishes phase 3 Year on year Swedish Orphan Biovitrum AB (publ) had little change in net income (from 3.31bn to 3.25bn) despite revenues that grew 7.11% from 14.25bn to 15.26bn. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 24.49% to 26.26%.


Privat skola kalmar
kolla reg nr bil

Swedish Orphan Biovitrum - aktiekurs, analyser, insiders

Swedish Orphan Biovitrum AB (publ). kr 144.40-1.77%. Electrolux Professional publ AB. kr 50.26-1.14%. Fingerprint Cards AB. kr 31.32-3.15  Svenska Handelsbanken AB Class A. kr 94.32-0.55%. Boliden AB. kr 322.80+0.62%. Swedish Orphan Biovitrum AB (publ). kr 136.10-1.27%.